4.5 Article

Single-nucleotide polymorphisms (SNPs) and haplotype analysis in vascular endothelial growth factor (VEGF) gene in the patients with Parkinson disease and lung cancer

Journal

ARCHIVES OF GERONTOLOGY AND GERIATRICS
Volume 48, Issue 3, Pages 287-290

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.archger.2008.02.007

Keywords

Parkinson disease; Lung cancer; Co-morbidity; Vascular endothelial growth factor (VEFG); Single-nucleotide polymorphisms (SNPs); Haplotype

Funding

  1. Korean Health 21 RD Project [00-PJ3-PG6-GN02-0002]
  2. Ministry of Health and Welfare, Republic of Korea

Ask authors/readers for more resources

The epidemiologic data on smoking in association with Parkinson disease (PD) is puzzling. A lower incidence of smoking-related malignancies, especially lung cancer, has been reported by several studies in the patients with PD. In this study, we investigated polymorphic variations in the vascular endothelial growth factor (VEGF) gene, which has been proposed having a pivotal role in progressive damage of nigral dopaminergic neurons, between Korean patients with 188 PD and 321 lung cancer patients. There were no significant differences in the tested single-nucleotide polymorphisms (SNPs) between patients with PD and lung cancer; however, one haplotype was significantly different in comparisons between the two diseases. These results suggest that VEGF genetic polymorphisms might help understand the low incidence of lung cancer in the patients with PD. (c) 2008 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available